Contract Research Organization Market Trends

ID: MRFR/HS/2389-CR

90 Pages

Rahul Gotadki

July 2025

Contract Research Organization (CRO) Market Research Report By Service Type (Clinical Research Services, Preclinical Services, Laboratory Services, Consulting Services), By Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Diseases, Endocrinology), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic Institutions), By Phase of Development (Preclinical, Phase I, Phase II, Phase III, Phase IV) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) -... read more

Contract Research Organization Market Infographic

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Contract Research Organization Market

In recent years, the Contract Research Organization (CRO) market has experienced significant growth and transformation, driven by several key trends. One prominent trend is the increasing outsourcing of research and development activities by pharmaceutical, biotechnology, and medical device companies. As these organizations seek to streamline operations, reduce costs, and access specialized expertise, they are turning to CROs to conduct various aspects of clinical trials, preclinical research, and regulatory affairs.

Moreover, the demand for CRO services has been fueled by the expanding global pharmaceutical and biotechnology industries, particularly in emerging markets such as Asia-Pacific and Latin America. These regions offer several advantages, including access to large patient populations, lower operating costs, and increasingly sophisticated regulatory frameworks. As a result, many CROs are expanding their presence in these markets, establishing partnerships with local institutions, and adapting their services to meet the unique requirements of diverse regulatory environments.

Another notable trend in the CRO market is the growing emphasis on specialized services and niche expertise. With the increasing complexity of drug development processes and regulatory requirements, there is a growing demand for CROs that can provide specialized services in areas such as biomarker analysis, genomics, pharmacovigilance, and real-world evidence generation. This trend has led to the emergence of boutique CROs and niche service providers that cater to specific therapeutic areas or technological platforms, offering clients tailored solutions and deep domain expertise.

Furthermore, technological advancements and digital innovations are reshaping the landscape of the CRO market. The adoption of digital health technologies, data analytics, artificial intelligence, and machine learning has the potential to enhance the efficiency, accuracy, and speed of clinical trials and research processes. CROs are increasingly leveraging these technologies to optimize trial design, patient recruitment, data collection, and analysis, thereby accelerating the drug development timeline and improving the probability of success for clinical programs.

In addition to technological innovations, there is a growing focus on patient-centricity and decentralized trial approaches within the CRO industry. Recognizing the importance of patient engagement, diversity, and inclusivity in clinical research, CROs are implementing strategies to enhance patient recruitment and retention, improve patient experience, and facilitate remote participation in clinical trials. Decentralized trial models, which leverage digital tools and virtual technologies to conduct aspects of clinical research outside of traditional clinical settings, are gaining traction as a means to overcome barriers related to patient access, participation, and compliance.

Moreover, regulatory dynamics and compliance requirements continue to shape the landscape of the CRO market. The evolving regulatory landscape, including changes in data privacy regulations, clinical trial transparency requirements, and quality standards, is driving CROs to enhance their regulatory expertise, risk management capabilities, and compliance practices. Furthermore, the increasing scrutiny of clinical research practices and the growing demand for transparency and accountability are prompting CROs to adopt robust quality management systems, implement rigorous internal controls, and demonstrate adherence to ethical standards and regulatory guidelines.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected market valuation of the Contract Research Organization (CRO) market by 2035?

The projected market valuation of the CRO market by 2035 is 170.63 USD Billion.

What was the overall market valuation of the CRO market in 2024?

The overall market valuation of the CRO market in 2024 was 84.3 USD Billion.

What is the expected CAGR for the CRO market during the forecast period 2025 - 2035?

The expected CAGR for the CRO market during the forecast period 2025 - 2035 is 6.62%.

Which service type segment had the highest valuation in 2024?

In 2024, the Clinical Research Services segment had the highest valuation at 85.0 USD Billion.

What are the key therapeutic areas driving growth in the CRO market?

Key therapeutic areas driving growth include Oncology, Cardiology, and Neurology, with valuations reaching up to 65.0, 40.0, and 30.0 USD Billion respectively.

Who are the leading players in the CRO market?

Leading players in the CRO market include IQVIA, Labcorp Drug Development, and Charles River Laboratories.

What is the valuation range for preclinical services in the CRO market?

The valuation range for preclinical services in the CRO market is between 20.0 and 40.0 USD Billion.

Which end user segment is expected to dominate the CRO market?

The Pharmaceutical Companies segment is expected to dominate the CRO market, with a valuation range of 40.0 to 85.0 USD Billion.

What is the valuation range for Phase III development in the CRO market?

The valuation range for Phase III development in the CRO market is between 25.0 and 50.0 USD Billion.

How does the CRO market's growth compare across different service types?

The CRO market's growth varies, with Clinical Research Services leading, followed by Preclinical Services and Laboratory Services, indicating diverse demand across service types.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Contract Research Organization Market (CRO) Market Size was estimated at 84.3 USD Billion in 2024. The CRO industry is projected to grow from 89.88 USD Billion in 2025 to 170.63 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 6.62 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Contract Research Organization Market (CRO) market is poised for substantial growth driven by technological advancements and increasing demand for specialized services.

North America remains the largest market for CRO services, reflecting a robust demand for clinical research. The Asia-Pacific region is emerging as the fastest-growing market, fueled by expanding biopharmaceutical activities. Clinical research services dominate the CRO landscape, while preclinical services are witnessing rapid growth. Rising R&D expenditure and the growing complexity of clinical trials are key drivers propelling market expansion.

Contract Research Organization Market

CAGR

6.62%

Market Size & Forecast

2024 Market Size	84.3 (USD Billion)
2035 Market Size	170.63 (USD Billion)
CAGR (2025 - 2035)	6.62%
Largest Regional Market Share in 2024	North America

Major Players

<a href="https://www.iqvia.com/solutions/research-and-development">IQVIA</a> (US), Labcorp Drug Development (US), PPD (US), <a href="https://www.syneoshealth.com/">Syneos Health</a> (US), Charles River Laboratories (US), Covance (US), Medpace (US), PRA Health Sciences (US), Wuxi AppTec (CN), KCR (PL)

Market Trends

The Contract Research Organization Market (CRO) Market is currently experiencing a dynamic evolution, driven by the increasing complexity of clinical trials and the growing demand for outsourcing services. Pharmaceutical and biotechnology companies are increasingly relying on CROs to manage various aspects of research and development, which allows them to focus on their core competencies. This trend appears to be fueled by the need for cost efficiency, faster time-to-market, and access to specialized expertise. As a result, CROs are expanding their service offerings, incorporating advanced technologies, and enhancing their operational capabilities to meet the diverse needs of their clients. Moreover, the landscape of the Contract Research Organization Market (CRO) Market is characterized by a shift towards strategic partnerships and collaborations. Companies are seeking to leverage the strengths of CROs to navigate regulatory challenges and optimize clinical trial designs. This collaborative approach not only enhances the quality of research but also fosters innovation in drug development processes. The market seems poised for further growth as stakeholders recognize the value of CROs in accelerating the delivery of new therapies to patients. Overall, the Contract Research Organization Market (CRO) Market is likely to continue evolving, reflecting the changing dynamics of the healthcare industry and the increasing importance of research outsourcing.

Technological Advancements

The integration of cutting-edge technologies, such as artificial intelligence and machine learning, is transforming the Contract Research Organization Market (CRO) Market. These innovations enhance data analysis, streamline operations, and improve patient recruitment processes, thereby increasing the efficiency of clinical trials.

Regulatory Compliance Focus

There is a growing emphasis on regulatory compliance within the Contract Research Organization Market (CRO) Market. As regulations become more stringent, CROs are adapting their practices to ensure adherence, which may enhance their credibility and attract more clients seeking reliable partners.

Increased Demand for Specialized Services

The demand for specialized services, including rare disease research and personalized medicine, is on the rise in the Contract Research Organization Market (CRO) Market. This trend indicates a shift towards tailored solutions that address specific therapeutic areas, reflecting the evolving needs of pharmaceutical companies.

Contract Research Organization Market Market Drivers

Rising R&D Expenditure

The increasing investment in research and development (R&D) by pharmaceutical and biotechnology companies appears to be a primary driver for the Contract Research Organization Market (CRO) Market. As companies strive to innovate and bring new therapies to market, they allocate substantial budgets towards R&D. In recent years, R&D spending has surged, with estimates indicating that it could reach over 200 billion USD annually by 2025. This trend necessitates the outsourcing of clinical trials and other research activities to CROs, which can provide specialized expertise and resources. Consequently, the demand for CRO services is likely to grow, as companies seek to enhance efficiency and reduce time-to-market for new drugs. This dynamic underscores the pivotal role of CROs in facilitating the R&D processes of their clients.

Expansion of Biopharmaceutical Sector

The expansion of the biopharmaceutical sector is a notable driver for the Contract Research Organization Market (CRO) Market. With the biopharmaceutical industry experiencing robust growth, driven by advancements in biotechnology and personalized medicine, the demand for CRO services is expected to increase. Reports indicate that the biopharmaceutical market could surpass 500 billion USD by 2025, creating a substantial need for outsourced research services. CROs are well-positioned to support biopharmaceutical companies in navigating the complexities of drug development, including preclinical and clinical phases. This growth trajectory suggests that CROs will play an essential role in the success of biopharmaceutical innovations, further solidifying their importance in the research ecosystem.

Growing Complexity of Clinical Trials

The increasing complexity of clinical trials is another significant factor influencing the Contract Research Organization Market (CRO) Market. As therapies become more sophisticated, the design and execution of clinical trials require advanced methodologies and technologies. This complexity often leads sponsors to seek the expertise of CROs, which possess the necessary capabilities to manage multifaceted trials effectively. Data suggests that the number of clinical trials has been on the rise, with thousands of new studies initiated each year. This trend indicates a growing reliance on CROs to navigate regulatory requirements, patient recruitment, and data management. As the landscape of clinical research evolves, the role of CROs in ensuring successful trial outcomes becomes increasingly critical.

Increased Focus on Patient-Centric Approaches

The heightened emphasis on patient-centric approaches in clinical research is reshaping the Contract Research Organization Market (CRO) Market. As stakeholders recognize the importance of patient engagement and experience, CROs are adapting their strategies to incorporate patient feedback and preferences into trial designs. This shift is likely to enhance recruitment and retention rates, ultimately leading to more successful trials. Data indicates that patient-centric trials can improve enrollment by up to 30%, which is a compelling incentive for sponsors to collaborate with CROs that prioritize these methodologies. As the industry continues to evolve towards a more patient-focused paradigm, the demand for CROs that can deliver on these expectations is expected to rise.

Technological Integration in Research Processes

The integration of advanced technologies into research processes is a transformative driver for the Contract Research Organization Market (CRO) Market. Innovations such as artificial intelligence, machine learning, and big data analytics are revolutionizing how clinical trials are designed and executed. These technologies enable CROs to streamline operations, enhance data accuracy, and improve decision-making processes. As the industry increasingly adopts these technological solutions, the efficiency and effectiveness of research activities are likely to improve significantly. Reports suggest that the adoption of technology in clinical trials could reduce costs by up to 20%, making CROs more attractive partners for pharmaceutical companies. This trend indicates a promising future for CROs that embrace technological advancements in their service offerings.

Market Segment Insights

Contract Research Organization Market (CRO) Market Service Type Insights

The Contract Research Organization Market (CRO) Market, particularly focusing on the Service Type segment, reveals a robust landscape with a projected market valuation reaching 46.99 USD Billion by 2024. This growth trajectory sets the stage for continued expansion as the market is expected to climb to 75.0 USD Billion by 2035.

Within this framework, the Clinical Research Services segment significantly leads, boasting a value of 18.0 USD Billion in 2024 and escalating to 28.5 USD Billion by 2035, thus holding a majority share in the CRO landscape.This segment is pivotal as it encompasses essential services for the development of new therapies, catering to the increasing demand for effective clinical trials and regulatory compliance. Following closely is the Preclinical Services segment, which is expected to add substantial value, starting at 12.5 USD Billion in 2024 and rising to 19.0 USD Billion by 2035.

This growth can be attributed to the increasing need for safety evaluations prior to initiating human studies, establishing preclinical services as a critical step in the drug development process.Additionally, the Laboratory Services segment, valued at 8.0 USD Billion in 2024 and anticipated to reach 12.5 USD Billion by 2035, plays a vital role in supporting R&D efforts through essential testing and analysis, ensuring that data integrity and accuracy are maintained throughout the research process.

Contract Research Organization Market (CRO) Market Therapeutic Area Insights

The Contract Research Organization Market (CRO) Market within the Therapeutic Area segment is on a growth trajectory, reflective of a broader global trend in healthcare innovation and research facilitation. As the overall market is projected to achieve a value of 46.99 Billion USD by 2024, the demand for specialized services in various therapeutic domains increases. Oncology stands out as a significant area of focus, driven by the rising incidence of cancer cases worldwide and the need for advanced research methodologies.

Following closely are Cardiology and Neurology, both of which require bespoke research solutions due to the intricate nature of their disorders and the continuous advancement of treatment modalities.Infectious Diseases has also gained prominence, particularly post-pandemic, highlighting the necessity for rapid and effective clinical trials. <a href="https://www.marketresearchfuture.com/reports/endocrinology-drugs-market-43410">Endocrinology Drugs</a> remains pivotal as diabetes and hormonal disorders continue to surge. The market's diversity in therapeutic areas allows for targeted research and tailored operational strategies, accommodating the unique needs of biopharmaceutical clients while exploring innovative solutions for healthcare challenges globally.

The value of the Contract Research Organization Market (CRO) Market data and its segmentation underscores the importance of dynamic research in enhancing patient outcomes and streamlining drug development processes.

Contract Research Organization Market (CRO) Market End User Insights

The Contract Research Organization Market (CRO) Market is experiencing notable growth, with a projected valuation of approximately USD 46.99 billion in 2024, escalating to USD 75.0 billion by 2035. This market is primarily driven by the increasing need for innovative drug development solutions, which is crucial for Pharmaceutical Companies and Biotechnology Companies that heavily rely on outsourced research and development services to enhance their operational efficiency and speed to market.

Medical Device Companies are also significantly engaged in this market, leveraging CROs to navigate regulatory complexities and ensure faster product approvals.Furthermore, Academic Institutions are increasingly collaborating with CROs to facilitate clinical studies and advance medical research, benefiting from specialized expertise and resources. The Contract Research Organization Market (CRO) Market segmentation reflects a diverse landscape where Pharmaceutical Companies hold a major share, considering their continuous demand for efficient clinical trial management, whereas Biotechnology Companies thrive on collaborations that expedite biopharmaceutical research. Opportunities in tailored solutions and technological advancements further encourage growth within these user segments, despite challenges like stringent regulations and competition.

Overall, the market landscape emphasizes a strategic partnership approach where CROs play an instrumental role in supporting innovation across multiple sectors within the global healthcare ecosystem.

Contract Research Organization Market (CRO) Market Phase of Development Insights

The Contract Research Organization Market (CRO) Market is significantly influenced by the Phase of Development segment, which encompasses various stages from Preclinical to Phase IV. In the rapidly evolving landscape of pharmaceutical Research and Development, the Preclinical phase plays a crucial role as it focuses on identifying drug candidates through laboratory research and animal testing, laying the groundwork for further clinical studies.

Phase I trials are essential for evaluating safety and dosage in a small group of healthy volunteers or patients, crucial for establishing the foundation for subsequent phases.Phase II focuses on efficacy, often involving larger patient groups to gain a better understanding of how the drug works in specific populations. Following this, Phase III trials are pivotal for confirming effectiveness and monitoring adverse reactions in larger populations, serving as a critical step before seeking regulatory approval and market entry.

Finally, Phase IV, or post-marketing surveillance, continues to gather data on the drug's long-term effects and overall benefit-risk relationship in the general population. Collectively, these phases are integral to ensuring the safety and efficacy of new therapies and significantly contribute to the Contract Research Organization Market (CRO) Market revenue, with various dynamics driving market growth and presenting challenges for stakeholders.The Contract Research Organization Market (CRO) Market data indicates that advancements in technology, increasing prevalence of chronic diseases, and a surge in demand for innovative therapies are fueling this growth, making understanding these phases vital for industry participants.

Get more detailed insights about Contract Research Organization Market Research Report – Forecast till 2035

Regional Insights

North America : Leading Innovation and Growth

North America remains the largest market for Contract Research Organizations (CROs), holding approximately 45% of the global market share. The region's growth is driven by a robust pharmaceutical sector, increasing R&D investments, and favorable regulatory frameworks. The demand for outsourcing clinical trials and research services is on the rise, fueled by the need for cost efficiency and accelerated drug development timelines. The United States is the primary player in this market, with key companies like IQVIA, Labcorp, and PPD leading the charge. The competitive landscape is characterized by a mix of large multinational firms and specialized CROs, ensuring a diverse service offering. Canada also plays a significant role, contributing to the region's overall market strength with its supportive regulatory environment and growing biotech sector.

Europe : Emerging Regulatory Landscape

Europe is the second-largest market for Contract Research Organizations, accounting for approximately 30% of the global market share. The region's growth is propelled by increasing investments in biopharmaceutical research, a strong emphasis on innovation, and evolving regulatory frameworks that facilitate clinical trials. The European Medicines Agency (EMA) has been instrumental in streamlining processes, which enhances the attractiveness of the region for CRO services. Leading countries in this market include Germany, the UK, and France, each contributing significantly to the CRO landscape. The competitive environment features both established players and emerging firms, fostering innovation and collaboration. Companies like Covance and Charles River Laboratories are key players, leveraging their expertise to meet the growing demand for clinical research services across Europe.

Asia-Pacific : Rapid Growth and Expansion

Asia-Pacific is witnessing rapid growth in the Contract Research Organization Market, holding approximately 20% of the global market share. The region's expansion is driven by increasing healthcare expenditure, a growing number of clinical trials, and a shift towards outsourcing by pharmaceutical companies. Countries like China and India are becoming attractive destinations for CRO services due to their large patient populations and cost-effective solutions. China is emerging as a leader in the CRO market, supported by government initiatives to boost the pharmaceutical sector. India also plays a crucial role, with a burgeoning biotech industry and a skilled workforce. The competitive landscape is evolving, with both local and international players vying for market share, enhancing the overall service offerings in the region.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually emerging in the Contract Research Organization Market, currently holding about 5% of the global market share. The growth is driven by increasing investments in healthcare infrastructure, rising clinical trial activities, and a focus on improving healthcare outcomes. Countries like South Africa and the UAE are leading the way, supported by government initiatives to enhance research capabilities and attract foreign investments. The competitive landscape is still developing, with a mix of local and international CROs entering the market. South Africa is particularly notable for its diverse patient population and established regulatory framework, making it an attractive site for clinical trials. The presence of key players is growing, as they seek to capitalize on the region's untapped potential and expanding healthcare needs.

Key Players and Competitive Insights

The Contract Research Organization Market (CRO) Market is characterized by a dynamic landscape marked by the presence of numerous key players who offer a diverse range of services to the biopharmaceutical and life sciences industries. These organizations play a pivotal role in conducting research and providing essential support to companies in the areas of drug development, clinical trials, and regulatory affairs. The market is competitive due to the growing demand for outsourced research services, cost-effective solutions, and the need for faster market entry of innovative therapies.

CROs are constantly evolving and expanding their capabilities through strategic partnerships, mergers, and acquisitions to enhance their service offerings, thereby gaining a competitive edge within the industry.Charles River Laboratories has established itself as a prominent player in the Contract Research Organization Market (CRO) Market. The company has a comprehensive suite of services that encompasses early-stage research, preclinical services, laboratory services, and focused solutions tailored to support drug development. With a strong global presence, Charles River Laboratories leverages its extensive experience and expertise, which is underpinned by a robust infrastructure.

The company has consistently been recognized for its commitment to quality and reliability, which solidifies its reputation among clients. The emphasis on innovation allows Charles River Laboratories to adapt to the evolving demands of the market, positioning it as a trusted partner for pharmaceutical companies, biotech firms, and academic institutions involved in drug research and development.Parexel International is another significant competitor within the Contract Research Organization Market (CRO) Market, known for its extensive array of services that span clinical research, regulatory consulting, and commercialization strategies.

The company's global reach enables it to effectively cater to diverse client needs, offering tailored solutions that address various phases of drug development from preclinical all the way to post-market activities.

Parexel International has distinguished itself by focusing on partnerships and collaborations with stakeholders, which often leads to successful mergers and acquisitions that enhance its service delivery and technological capabilities. With an emphasis on innovation and adherence to regulatory standards, Parexel International continues to strengthen its position in the market, ensuring that its clients achieve their research objectives while navigating the complexities of the global healthcare environment.

Key Companies in the Contract Research Organization Market market include

Industry Developments

In recent months, the Contract Research Organization Market (CRO) Market has seen significant developments, particularly with major companies expanding their capabilities and market presence. In October 2023, Charles River Laboratories announced the expansion of its preclinical and clinical services to meet increasing demand from biopharmaceutical companies. Meanwhile, in September 2023, PPD was acquired by Thermo Fisher Scientific, a move that strengthens its position in the biopharmaceutical services sector.

Additionally, Advanced Clinical has been making strides in enhancing its operational efficiencies through innovative technologies, which reflects the ongoing trend towards digital transformation within the industry. Market valuations for companies like IQVIA and Syneos Health have surged due to their extensive service offerings and strategic partnerships.

Over the past few years, between 2021 and 2023, the CRO market has experienced robust growth, fueled by increasing R&D expenditures and rising demand for clinical trial services globally, especially in regions such as North America and Europe. This growth is also accompanied by regulatory changes that aim to streamline the clinical trial processes, further propelling the market forward as evidenced by ongoing collaborations and investments in technology by various CROs.

Future Outlook

Contract Research Organization Market Future Outlook

The Contract Research Organization Market (CRO) Market is projected to grow at a 6.62% CAGR from 2024 to 2035, driven by technological advancements, increasing R&D investments, and a rising demand for outsourcing.

New opportunities lie in:

Expansion of decentralized clinical trial servicesDevelopment of AI-driven data analytics platformsStrategic partnerships with biotech firms for innovative therapies

By 2035, the CRO market is expected to be robust, reflecting substantial growth and diversification.

Market Segmentation

Contract Research Organization Market End User Outlook

Pharmaceutical Companies
Biotechnology Companies
Medical Device Companies
Academic Institutions

Contract Research Organization Market Service Type Outlook

Clinical Research Services
Preclinical Services
Laboratory Services
Consulting Services

Contract Research Organization Market Therapeutic Area Outlook

Oncology
Cardiology
Neurology
Infectious Diseases
Endocrinology

Contract Research Organization Market Phase of Development Outlook

Preclinical
Phase I
Phase II
Phase III
Phase IV

Report Scope

MARKET SIZE 2024	84.3(USD Billion)
MARKET SIZE 2025	89.88(USD Billion)
MARKET SIZE 2035	170.63(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.62% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Integration of advanced analytics and artificial intelligence in the Contract Research Organization (CRO) Market.
Key Market Dynamics	Rising demand for outsourcing Research and Development drives competitive dynamics in the Contract Research Organization market.
Countries Covered	North America, Europe, APAC, South America, MEA